SCHEMBL3562464

SCHEMBL3562464

O=C(O)c1ccc2[nH]c(-c3ccc(C(=O)c4cccs4)cc3)nc2c1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHEK2 O96017 8/20 0.67
KDM4E B2RXH2 4/20 0.53
ALDH1A1 P00352 4/20 0.53
HPGD P15428 3/20 0.53
KMT2A Q03164 2/20 0.53
MAPT P10636 4/20 0.51
SMN1; SMN2 Q16637 2/20 0.51
APAF1 O14727 1/20 0.51
POLB P06746 1/20 0.51
PPARG P37231 1/20 0.51
RECQL P46063 1/20 0.51
SMAD3 P84022 1/20 0.51
PTK2B Q14289 1/20 0.51
ESR2 Q92731 1/20 0.51
NR2E3 Q9Y5X4 1/20 0.51
NCOR2 Q9Y618 1/20 0.51
RAB9A P51151 2/20 0.50
NR4A2 P43354 1/20 0.50
NPC1 O15118 2/20 0.48
MMP2 P08253 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5679984 0.91 CHEK2 (0.81) CHEK2KDM4EALDH1A1HPGDKMT2A
SCHEMBL3568350 0.90 CHEK2 (0.83) CHEK2KDM4EALDH1A1HPGDKMT2A
SCHEMBL3560621 0.84 KDM4E (0.66) CHEK2KDM4EALDH1A1HPGDKMT2A
SCHEMBL28930292 0.83 KDM4E (0.68) CHEK2KDM4EALDH1A1HPGDKMT2A
SCHEMBL5178313 0.83 CHEK2 (0.66) CHEK2KDM4EALDH1A1HPGDKMT2A
SCHEMBL7602620 0.82 KDM4E (0.70) CHEK2KDM4EALDH1A1HPGDKMT2A
SCHEMBL3565165 0.82 CHEK2 (0.64) CHEK2KDM4EALDH1A1HPGDKMT2A
SCHEMBL8611783 0.81 KDM4E (0.69) CHEK2KDM4EALDH1A1HPGDKMT2A
SCHEMBL5676301 0.81 CHEK2 (1.00) CHEK2
SCHEMBL21623639 0.80 HDAC3 (0.60) CHEK2KDM4EALDH1A1HPGDKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7687639-B2 Substituted benzimidazoles and imidazo-[4,5]-pyridines JANSSEN PHARMACEUTICA N.V. (BE) 2010-03-30 US disclosed
US-20060252793-A1 Substituted benzimidazoles and imidazo-[4,5]-pyridines BW CONVERTING AB (SE) 2006-11-09 US disclosed
US-7132440-B2 Substituted benzimidazoles and imidazo-[4,5]-pyridines JANSSEN PHARMACEUTICA, N.V. (BE) 2006-11-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060252793-A1 Substituted benzimidazoles and imidazo-[4,5]-pyridines CDKN1A, DDB1, TMBIM6 CHEK2 14/4885KDM4E 3815/4885ALDH1A1 1427/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.